Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2024 Earnings

2MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-10.87

-4.37

2.12

8.62

Details

Expected EPS

-5.703430431

Actual EPS

-2.65746

Surprise EPS

3.05

Surprise Percent

+53.41%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -2.65746 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.